Eliad Karin
Oncology · 2009–2010
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 54 citations into it; #896 of 1,698 by trust here, #641 by citations
- Immunology — 50 citations into it
Whom Eliad Karin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Eliad Karin overall
Papers from Eliad Karin's perspective
Ordered by how strongly the researchers Eliad Karin trusts endorse each paper. Same corpus, a different order for every researcher.
- Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens (Nature Medicine)
- Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells (Nature Medicine)
- Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. (Journal of Clinical Investigation)
- The fundamental basis of inflammatory bowel disease. (Journal of Clinical Investigation)
- cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine* (Journal of Biological Chemistry)
- NF-κB functions as a tumour promoter in inflammation-associated cancer (Nature)
- Interleukin-6: from basic science to medicine--40 years in immunology. (Annual Review of Immunology)
- Inflammation and cancer (Nature)
- TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. (Immunity)
- The risk of colorectal cancer in ulcerative colitis: a meta-analysis (Gut)
Their papers
- Inflammation and colon cancer. (2010) — 1,989 citations
- IL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis associated cancer (2009) — 2,165 citations